Your session is about to expire
← Back to Search
Behavioural Intervention
Noninvasive Brain Stimulation + Music-Assisted Therapy for Traumatic Brain Injury
N/A
Recruiting
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age between 18 and 75 years
Confirmed diagnosis of Acquired brain injury (individuals with stroke or Traumatic Brain Injury)
Must not have
Active history of migraine or chronic headache
Unable to move the hand because of muscle stiffness (scoring 3 or more on the Ashworth scale)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (before intervention), post-training (immediately after the end of 2-week intervention), followup (2 months after the end of intervention)
Summary
This trial will investigate the use of brain stimulation and music-assisted video game-based hand exercises to improve functional recovery in people with Acquired Brain Injury (ABI).
Who is the study for?
This trial is for adults aged 18-75 who have had a brain injury from stroke or trauma at least 6 months ago. They should be able to follow instructions, travel for multiple visits, and sit actively for 2 hours. Participants must have hand movement issues but can't join if they have severe eyesight problems, epilepsy history, skin scalp damage, extreme muscle stiffness in the hand, lost hand sensation, substance abuse history, certain mental illnesses or are pregnant.
What is being tested?
The study tests a combination of targeted noninvasive brain stimulation (HD-tDCS) and music-assisted video game exercises (MusicGlove) to improve hand functions in people with acquired brain injuries. It also examines changes in brain activity related to this intervention using EEG recordings before and after treatment.
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site on the scalp, headache or fatigue during or after sessions with HD-tDCS. The MusicGlove exercise is generally safe but might cause tiredness due to repetitive movements.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 75 years old.
Select...
I have been diagnosed with a brain injury from a stroke or trauma.
Select...
I can sit and be active for 2 hours without heart, breathing, or pain issues.
Select...
It has been over 6 months since my injury.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I frequently suffer from migraines or chronic headaches.
Select...
My hand is very stiff and I can't move it well.
Select...
I have or had tinnitus or severe hearing issues that were treated.
Select...
I or a family member have been diagnosed with epilepsy.
Select...
I have severe skin damage on my scalp.
Select...
I am on medication that could increase my risk of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (before intervention), post-training (immediately after the end of 2-week intervention), followup (2 months after the end of intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (before intervention), post-training (immediately after the end of 2-week intervention), followup (2 months after the end of intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change scores of Box and Block test (BBT)
Change scores of Upper-extremity Fugl-Myer Assessment (UEFMA)
Secondary study objectives
Change scores of Action Research Arm Test (ARAT)
Change scores of Dexterity and Speed Test (DAST)
Change scores of Nine Hole Peg Test (NHPT)
+3 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: MusicGlove and Active HD-tDCSActive Control2 Interventions
During Active HD-tDCS, current up to 2mA will be delivered transiently for only 30 seconds and it will be turned ON for the remainder of 20 minutes.
Group II: MusicGlove and Sham HD-tDCSPlacebo Group1 Intervention
During Sham HD-tDCS, current up to 2mA will be delivered transiently for only 30 seconds to simulate the real-tDCS based skin sensation.
Find a Location
Who is running the clinical trial?
Kessler FoundationLead Sponsor
184 Previous Clinical Trials
11,245 Total Patients Enrolled
Guang Yue, PhDStudy DirectorKessler Foundation
3 Previous Clinical Trials
90 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a tattoo with metal-based ink on your head or neck.I am between 18 and 75 years old.You are scared of small, enclosed spaces.I have been diagnosed with a brain injury from a stroke or trauma.You cannot feel or move your hand.You have a history of drinking too much alcohol or using illegal drugs.I frequently suffer from migraines or chronic headaches.My health is stable and I don't plan to change my medications soon.You have had mental health conditions like schizophrenia, anxiety, depression, or PTSD in the past.My hand is very stiff and I can't move it well.I can travel to and participate in all required visits for the study.You have trouble seeing well enough to read instructions on a computer screen.You have metal implants in your body, like surgical clips or a pacemaker.I have or had tinnitus or severe hearing issues that were treated.I have difficulty moving my hands and fingers.I can sit and be active for 2 hours without heart, breathing, or pain issues.I or a family member have been diagnosed with epilepsy.I have severe skin damage on my scalp.I am on medication that could increase my risk of seizures.It has been over 6 months since my injury.
Research Study Groups:
This trial has the following groups:- Group 1: MusicGlove and Active HD-tDCS
- Group 2: MusicGlove and Sham HD-tDCS
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.